NCT06320132 BLANDISH (Brain, Loss of Function, Aneurism, Disease, Injury, Stroke, Hemorrhage)
| NCT ID | NCT06320132 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IRCCS Ospedale San Raffaele |
| Condition | Intracranial Hemorrhages |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2024-03-13 |
| Primary Completion | 2028-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2024-03-13 with a primary completion date of 2028-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to train a machine learning system based on data from patients affected by spontaneous Intracranial Hemorrage. The main question it aims to answer is whether there is a correlation between actual clinical pratice, reached outcomes and favorable or unfavorable predictive factors, and anamnesis. Participants will be treated as per standard clinical practice.
Eligibility Criteria
Inclusion Criteria: * Patients who enter the NICU for acute spontaneous intracranial hemorrhage * Adult patients (≥ 18 years) * Sex: female, male, intersex Exclusion Criteria: * All patients affected by non-spontaneous ICH * Patients with sICH determined by brain tumor or brain metastases * All patients affected by chronic ICH * Pregnant and puerperal women * Refusal to participate in the protocol
Contact & Investigator
Francesca Guzzo, MD
PRINCIPAL INVESTIGATOR
IRCCS Ospedale San Raffaele
Frequently Asked Questions
Who can join the NCT06320132 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Intracranial Hemorrhages. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06320132 currently recruiting?
Yes, NCT06320132 is actively recruiting participants. Contact the research team at guzzo.francesca@hsr.it for enrollment information.
Where is the NCT06320132 trial being conducted?
This trial is being conducted at Milan, Italy.
Who is sponsoring the NCT06320132 clinical trial?
NCT06320132 is sponsored by IRCCS Ospedale San Raffaele. The principal investigator is Francesca Guzzo, MD at IRCCS Ospedale San Raffaele. The trial plans to enroll 2,000 participants.